Assessing whether RKT (referencing Rocket Pharmaceuticals or alternative tickers) is a suitable long-term investment depends heavily on clinical trial milestones, regulatory approval timelines, and balance sheet sustainability. What is your total investment budget and risk profile? Consulting a licensed financial advisor is recommended before making allocation changes.